Navigation Links
Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
Date:6/27/2008

xis' quality of science and productivity," said Paolo Poletti, MD, senior vice president of the Oncology Medicines Development Center at GSK.

"The GSK collaboration was critical to the development of Exelixis' world- class discovery group and our rapidly expanding clinical development group. Today, we have a pipeline of 11 compounds in clinical development, including XL184, which begins a phase 3 trial this summer," said George A. Scangos, president and chief executive officer of Exelixis. "This collaboration has been successful in that both companies have been able to share in the output of our discovery and development efforts and will be able to take forward multiple promising compounds with significant commercial potential in oncology. With the successful completion of the collaboration, we will have clarity regarding the exclusivity obligations under the GSK collaboration and ownership of the compounds in our pipeline."

To date, Exelixis has received approximately $235 million from GSK, which includes $150 million in upfront, milestone, and R&D support payments, and $85 million through a loan facility. Additionally, if GSK selects a second compound for further development, Exelixis will be entitled to receive an additional milestone payment of either $55 million or $27.5 million. The milestone will be due after the selected compound achieves proof-of-concept and will be creditable by GSK against amounts outstanding under the loan facility. Exelixis is eligible for development milestones and royalties on compounds selected for development and commercialization by GSK, which include XL880 and potentially one additional compound if GSK exercises its second development election. Exelixis will pay GSK a low, single-digit royalty on certain "Refused Candidates" that GSK elected not to choose with its development election which Exelixis thereafter successfully commercializes.

Background on Exelixis-GSK Collaboration

In October 2002, Exelixi
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  Saddleback Memorial Medical Center in ... the first hospital on the West Coast to perform ... surgical option provides women with a state-of-the-art, minimally invasive ... Marc Winter , M.D., a highly regarded ... medical director of minimally invasive surgery at Saddleback Memorial, ...
(Date:5/23/2013)... 23, 2013 On April 19th the ... supermarkets to search for the growing antibiotic resistant bacteria ... from a year long study were released late last ... specifically meats, over previous years. For those suffering from ... of antibiotic resistant bacteria in food, may eventually help ...
(Date:5/23/2013)... The New Jersey chapter of the largest organization ... (BDPA), is hosting its 10th annual Families in Technology ... will encourage students and their parents to explore the ... many of the industries’ finest teachers. Held from 9 ... of Technology, the event will include workshops, instruction and ...
(Date:5/23/2013)... Toronto, Canada (PRWEB) May 23, 2013 ... subjects, it is critical to adhere to principles ... protection (HSP). , Esteemed speaker Dr. Jeremy Lim, ... the audience: , ,     Understand the ... Clinical Practice (GCP) and additional regulations for the ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
... 4, 2010 Onda Corporation, the global leader in ... the latest additions to the hydrophone product family at ... is a new fiber optic hydrophone system that can ... applications of HITU. It is complemented with the release ...
... Consulting , a business unit of PAREXEL International (Nasdaq: ... serving the biopharmaceutical and medical device industries, today announced ... U.S. Food and Drug Administration’s (FDA) International Compliance Branch, ... its Strategic Compliance Services team, reporting directly to the ...
... - Scientists at the U.S. Department of Energy,s (DOE) ... fabricated transparent thin films capable of absorbing light and ... material, described in the journal Chemistry of Materials ... or even windows that absorb solar energy to generate ...
Cached Biology Technology:Onda Introduces a New Fiber Optic Hydrophone and Scanning Tank 2Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team 2Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team 3Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team 4Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team 5Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team 6Transparent conductive material could lead to power-generating windows 2
(Date:5/24/2013)... , Cancer cells spread and grow by avoiding ... the immune system can help to eliminate cancer cells; ... system to ignore cancer cells. Regulatory T cells are ... response. In this issue of the Journal of ... Stanford University found that regulatory T cells that infiltrate ...
(Date:5/24/2013)... leading water scientists from around the world today issued ... short span of one or two generations, the majority ... living under the handicap of severe pressure on fresh ... is no substitute. This handicap will be self-inflicted and ... pointed to chronic underlying problems led by mismanagement and ...
(Date:5/23/2013)... Health at Emory University, along with partners at ... $4 million grant over four years to establish ... Exposome Research Center: Understanding Lifetime Exposures). The grant ... the United States. , The HERCULES Center ... Health Sciences (NIEHS) of the National Institutes of ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
... Chinese government regulators had clearer skies and easier breathing ... temporarily shuttered some factories and banished many cars in ... that,s what they got. They were not ... satellites to measure the impact of air pollution controls. ...
... The first fuel-handling facility in the Galpagos ... given official environmental certification today, World Wildlife Fund ... in order to meet certification standards, which are ... and Toyota, in conjunction with the Ecuadorian Government, ...
... the University of Illinois and the University of Massachusetts ... bacteria,s evolutionary machinery into programming its own death. ... something in a bacteria that, in order to gain ... a suicide mutation," said Gerard Wong, a professor of ...
Cached Biology News:New satellite data reveal impact of Olympic pollution controls 2New satellite data reveal impact of Olympic pollution controls 3First fuel-handling facility in the Galapagos earns environmental certification 2Scientists fool bacteria into killing themselves to survive 2